Clinical & translational oncology

• 

  Año 2012, Vol. 14, Número 2

  • Neoadjuvant endocrine therapy: for whom, for how long?

    Fatima Cardoso

    págs. 81-82

    

  • Nanoparticle delivery systems for cancer therapy:: advances in clinical and preclinical research

    Susana Patricia Egusquiaguirre Martín, Manuela Igartua Olaechea, Rosa María Hernández Martín, José Luis Pedraz Muñoz

    • Resumen

    págs. 83-93

    

  • Tyrosine kinase inhibitors and drug interactions:: a review with practical recommendations

    Bella Pajares Hachero, Esperanza Torres Sánchez, José Manuel Trigo Pérez, María Isabel Sáez Medina, Nuria Ribelles Entrena, Begoña Jiménez, Emilio Alba

    • Resumen

    págs. 94-101

    

  • Review of Chinese clinical trials on CIK cell treatment for malignancies

    Xiao-Dong Li, Bin Xu, Jun Wu, Mei Ji, Bei-Hua Xu, Jing-Ting Jiang, Chang-Ping Wu

    • Resumen

    págs. 102-108

    

  • Ten-year results of a phase II study with a single fraction of high-dose-rate brachytherapy (FAST-boost) after whole breast irradiation in invasive breast carcinoma

    José Luis Guinot Rodríguez, Maribel Tortajada Azcutia, María Carrascosa Pérez, Vicente Crispín, Ana M. Otero Romero, Belén Ríos, Eleonor Rivín del Campo, Miguel Santos, Pablo Soler, Leoncio Arribas

    • Resumen

    págs. 109-115

    

  • Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma

    Jing-Jing Zhang, Yi Zhu, Yan Zhu, Jun-Li Wu, Wen-Biao Liang, Rong Zhu, Ze-Kuan Xu, Qing Du, Yi Miao

    • Resumen

    págs. 116-124

    

  • Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[+] operable breast cancer

    Antonio Llombart Cussac, Ángel Guerrero, Antonio Galán, Vicente Carañana, Elvira Buch Villa, Álvaro Rodríguez Lescure, Amparo Ruiz, Carlos Alberto Fuster Diana, Vicente Guillem Porta

    • Resumen

    págs. 125-131

    

  • Interobserver variability in target volume delineation in postoperative radiochemotherapy for gastric cancer.: A pilot prospective study

    Cristina Moretones Agut, David León, Arturo Navarro Martín, Olalla Santacruz, Ana Boladeras Inglada, Miquel Macià, María Cambray i Amenós, Valentí Navarro Pérez, Ignasi Modolell, Ferrán Guedea Edo

    • Resumen

    págs. 132-137

    

  • Examination of Smad2 and Smad4 copy-number variations in skin cancers

    Yong Shao, Jie Zhang, Richu Zhang, Jun Wan, Wei Zhang, Bo Yu

    • Resumen

    págs. 138-142

    

  • AK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma

    Zhenbing You, Dafu Xu, Jian Ji, Wei Guo, Weiguo Zhu, Jingdong He

    • Resumen

    págs. 143-149

    

  • Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy

    Lori E. Lowes, Michael Lock, George Rodrigues, David D´Souza, Glenn Bauman, Belal Ahmad, Varagur Venkatesan, Alison L. Allan, Tracy Sexton

    • Resumen

    págs. 150-156

    

  • CYP2D6*4 allele and breast cancer risk:: Is there any association?

    Ana Fernández Santander, Miguel del Saz Sánchez, Armando Tejerina Gómez, Fernando Bandrés Moya

    • Resumen

    págs. 157-159

    

  • Spanish Society of Medical Oncology (SEOM) Cancer and Thrombosis Working Group

    Andrés Jesús Muñoz Martín, Vanesa Pachón Olmos, Miguel Martín Jiménez, Emilio Alba, Juan Jesús Cruz Hernández

    • Resumen

    pág. 160